Healthcare Industry News: HSMN NewsFeed
News Release - October 1, 2010
K2M Enters Biologics Market with Launch of VIKOS Cervical Allograft SystemLEESBURG, Va.--(Healthcare Sales & Marketing Network)-- K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the launch of its first product in the spinal biologics market, the VIKOS™ Cervical Allograft System. K2M worked with LifeNet Health™, a leading allograft bio-implant and regenerative medicine company, to combine quality machined allograft implants with precision instrumentation.
VIKOS has been developed to support surgeon treatment of cervical pathologies with cortical ring and cortical-cancellous implant options in a wide range of sizes. The implants are designed with lordotic options for proper sagittal alignment and are treated with LifeNet Health’s proprietary PRESERVON® technology for storage at ambient temperature.
According to Dr. Jean-Jacques Abitbol at California Spine Group in San Diego, California, “The VIKOS Cervical Allograft System is an important addition to K2M’s portfolio. The VIKOS System provides comprehensive implant options and unique instrumentation.”
“K2M is excited to be partnering with such a high quality organization like LifeNet Health for our first product launch in the biomaterials sector,” stated Eric Major, K2M’s President and CEO. “The VIKOS Cervical Allograft System will address the high demand from the surgeon community to provide a wide range of interbody options.”
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and procedures. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.